The JuggerStitch implant consists of two soft anchors connected by a knotless, self-locking suture loop, instead of a traditional implant using a sliding knot to lock the repair.
The Warsaw, Ind.-based company said the device is designed to improve tissue preservation and improve control of tissue compression at the repair site in surgery.
“Zimmer Biomet is committed to delivering cutting-edge technology and solutions, like the next-generation JuggerStitch meniscal repair device, to help surgeons alleviate pain, restore peak performance and improve the quality of life for patients,” chief medical officer Dr. Andrew Freiberg said in prepared remarks. “Our comprehensive sports medicine portfolio provides a variety of options that help patients throughout the care continuum.”
“Traditional knotted meniscal fixator repair devices typically use hard plastic anchors and surface knots that can damage cartilage, increasing the risk of complications down the line,” added Dr. Keith Lawhorn of OrthoVirginia. “The JuggerStitch device offers a less invasive, all-suture, knotless approach to meniscal repair procedures and allows me to improve treatment outcomes for my patients.”
Shares of ZBH were down -0.4% at $138.20 per share in early-morning trading today.